91久久精品无码毛片国产高清

中證網
返回首頁

全國人大代表、華蘭生物董事長安康:加強疫苗接種門診建設

傅蘇穎 中國證券報·中證網

  中證網訊(記(ji)者 傅蘇(su)穎)全國人大代表、華蘭生物董事長(chang)安(an)康日前建議,今年(nian)為(wei)兩(liang)會準(zhun)備了加強疫(yi)苗接種(zhong)門(men)診建設、滿(man)足疫(yi)苗接種(zhong)需求的建議。

  安康表示,目前全(quan)國(guo)(guo)疾控中(zhong)心預防門診和社區衛(wei)生服(fu)務(wu)中(zhong)心共5萬多(duo)個疫(yi)苗接(jie)(jie)種(zhong)點,承(cheng)擔了(le)全(quan)國(guo)(guo)嬰(ying)幼(you)兒(er)(er)及成人的疫(yi)苗預防接(jie)(jie)種(zhong)。但現在的接(jie)(jie)種(zhong)門診大多(duo)是為兒(er)(er)童免疫(yi)規劃設立(li)的,已(yi)經不能適(shi)應成人接(jie)(jie)種(zhong)疫(yi)苗的需求。

  為此(ci),安康認為,有必要加強疫(yi)(yi)(yi)苗(miao)接(jie)種(zhong)點(dian)建(jian)(jian)設,滿足(zu)全人(ren)群的疫(yi)(yi)(yi)苗(miao)免疫(yi)(yi)(yi)接(jie)種(zhong)需求。安康建(jian)(jian)議,凡新建(jian)(jian)樓盤都(dou)要規劃(hua)(hua)社區(qu)門(men)診,社區(qu)門(men)診都(dou)由當地(di)衛生(sheng)健康委考核(he)準入具備(bei)疫(yi)(yi)(yi)苗(miao)接(jie)種(zhong)條件(jian),允許接(jie)種(zhong)非(fei)免疫(yi)(yi)(yi)規劃(hua)(hua)疫(yi)(yi)(yi)苗(miao)或(huo)用于成年人(ren)和老年人(ren)的疫(yi)(yi)(yi)苗(miao)。

  同時(shi)(shi)(shi),改(gai)變接種(zhong)(zhong)(zhong)(zhong)(zhong)(zhong)模(mo)式,增加接種(zhong)(zhong)(zhong)(zhong)(zhong)(zhong)時(shi)(shi)(shi)間。將(jiang)原(yuan)來上午(wu)開(kai)診,下午(wu)停診、只(zhi)開(kai)診半天的(de)接種(zhong)(zhong)(zhong)(zhong)(zhong)(zhong)模(mo)式,改(gai)成(cheng)全天接種(zhong)(zhong)(zhong)(zhong)(zhong)(zhong)。硬件(jian)上應該(gai)溫馨化(hua),讓無論(lun)是成(cheng)人還是兒童(tong)受種(zhong)(zhong)(zhong)(zhong)(zhong)(zhong)者,都感到舒(shu)適(shi)宜(yi)人。提高接種(zhong)(zhong)(zhong)(zhong)(zhong)(zhong)效(xiao)率,在(zai)服(fu)務(wu)供(gong)給方面,要(yao)(yao)考慮到服(fu)務(wu)全人群,制定接種(zhong)(zhong)(zhong)(zhong)(zhong)(zhong)流程的(de)效(xiao)率目標,在(zai)盡可能短的(de)時(shi)(shi)(shi)間內完成(cheng)接種(zhong)(zhong)(zhong)(zhong)(zhong)(zhong)服(fu)務(wu)。還要(yao)(yao)考慮到成(cheng)人接種(zhong)(zhong)(zhong)(zhong)(zhong)(zhong)的(de)方便性,至少安排雙休日提供(gong)一次服(fu)務(wu),即周日接種(zhong)(zhong)(zhong)(zhong)(zhong)(zhong),也可以在(zai)每個城市設立若干個24小時(shi)(shi)(shi)接種(zhong)(zhong)(zhong)(zhong)(zhong)(zhong)點,服(fu)務(wu)狂犬病(bing)疫苗(miao)等應急接種(zhong)(zhong)(zhong)(zhong)(zhong)(zhong),同時(shi)(shi)(shi)方便上班人群的(de)其(qi)他(ta)疫苗(miao)接種(zhong)(zhong)(zhong)(zhong)(zhong)(zhong)。

中證網聲明:凡本網注明“來源:中國證券報·中證網”的所有作品,版權均屬于中國證券報、中證網。中國證券報·中證網與作品作者聯合聲明,任何組織未經中國證券報、中證網以及作者書面授權不得轉載、摘編或利用其它方式使用上述作品。